Moreover, another study revealed that M2-type reprogramming of TAMs, coupled with the upregulation of CD47 in gefitinib-resistant lung cancer cells and tumor xenograft models, enables cancer cells to evade macrophage-mediated phagocytosis [40]. Here, CD47 is linked to neoplasm.